home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Medical Device Hazard Analysis Following ISO 14971 - 2017

 
  September 13, 2017  
     
 
Netzealous LLC DBA - Compliance4All, Online
2017-11-08


Overview:  
The US FDA expects that as part of a product development Design Control 

Program risk management will be conducted. FDA recommends using ISO 

14971 as a guide and has accepted it as a recognized standard.

Why should you Attend: 
FDA expects that as part of a product development program risk management 

will be conducted. FDA recommends using ISO 14971 as a guide and has 

accepted it as a recognized standard. 

Areas Covered in the Session:
Explanation of Hazard Analysis terms
Hazard Analysis Process Explanation using a Template
Examples of Terms will be given
Hazard Analysis Examples will be Covered Step by Step

Who Will Benefit:
Engineer
Engineering Manager
Regulatory Personnel
QA

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
 
 
Organized by: Event Manager
Invited Speakers:
Speaker Profile:
Edwin Waldbusser is a consultant retired from industry after 20 years in 
management of development of medical devices (5 patents). He has been 
consulting in the US and internationally in the areas of design control, risk 
analysis and software validation for the past 8 years. Mr. Waldbusser has a 
BS in Mechanical Engineering and an MBA.
 
Deadline for Abstracts: 2017-11-07
 
Registration:

Full Details & Registration Link:

http://www.compliance4all.com/control/w_product/~product_id=501363LIVE?channel=molgen_Nov_2017_SEO 

E-mail: support@compliance4All.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.